This is a preview of subscription content, log in via an institution to check access.
Reference
Pina JM, et al. Cost-effectiveness of rifampin for 4 months and isoniazid for 9 months in the treatment of tuberculosis infection. European Journal of Clinical Microbiology and Infectious Diseases : 13 Dec 2012. Available from: URL: http://dx.doi.org/10.1007/s10096-012-1788-2
Rights and permissions
About this article
Cite this article
Rifampicin preferred option for LTBI control. PharmacoEcon Outcomes News 670, 9 (2013). https://doi.org/10.1007/s40274-013-0103-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0103-5